Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2003
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003CN1402723A 3-(4,5-dihydroisoxazol-3-yl)-substd. benzoylpyrazoles as herbicides
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402715A Processes for production of oxadiazoline derivs.
03/12/2003CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1402636A Pharmaceutical formulations contg. zolmitriptan
03/11/2003US6531611 Process for making taxane derivatives
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531609 Process for the preparation of thiazolidinedione derivatives
03/11/2003US6531503 Benzofurane derivatives
03/11/2003US6531497 Epothilone derivatives and their synthesis and use
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531470 Oxazolidinone combinatorial libraries, compositions and methods of preparation
03/11/2003US6531469 Substituted 1-(4-piperidyl)-3-(aryl) isothioureas their preparation and their therapeutic application
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/11/2003CA2262837C An asymmetric conjugate addition reaction
03/11/2003CA2146250C Process for preparing taxane derivatives
03/11/2003CA2146155C Process for preparing taxane derivatives
03/07/2003WO2002020531A2 Method for producing anellated tetrahydro-[1h]-triazoles
03/07/2003CA2421839A1 Method for producing anellated tetrahydro-[1h]-triazoles
03/06/2003WO2003018577A1 Antiviral nucleoside derivatives and process for preparing the same
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018553A1 Oral antidiabetic agents
03/06/2003WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors
03/06/2003WO2003018022A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
03/06/2003WO2003018021A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003WO2003018009A1 A combination of quetiapine and zolmitriptan
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002085849A3 Process to prepare oxazolidinones
03/06/2003WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003WO2002020516A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
03/06/2003US20030045715 Useful in treating and suppressing human Cytomegalovirus
03/06/2003US20030045711 Epothilone derivatives and methods for making and using the same
03/06/2003US20030045558 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides)
03/06/2003US20030045554 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
03/06/2003US20030045546 Anticancer agents
03/06/2003US20030045519 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
03/06/2003US20030044399 Method of treatment
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458011A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
03/06/2003CA2457838A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003CA2456480A1 A combination of quetiapine and zolmitriptan
03/06/2003CA2421499A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the same and pharmaceutical agent containing the same as active ingredient
03/05/2003EP1286998A1 Oxazolidinone derivatives with antibiotic activity
03/05/2003EP1286991A2 Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substitued benzoylpyrazoles
03/05/2003EP1286988A2 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
03/05/2003EP1286987A1 Heterocyclic hydrazones for use as anti-cancer agents
03/05/2003EP1286985A1 Substituted pyridine herbicides
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286974A2 Medicament for viral diseases
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1202984B1 diphenyl-piperidine derivate
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP0869786B1 Pharmaceutical compounds
03/05/2003EP0832069B1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
03/05/2003EP0627433B1 Process for producing imidazopyridine derivative and intermediate
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound
03/04/2003US6528525 Amidocarboxylic acid derivatives
03/04/2003US6528510 HIV protease inhibitors
03/04/2003US6528504 Compounds such as (R)-5,11-dihydro-5-(1-(4-methoxyphenethyl)-piperidine-2-ylmethyl) -dibenzo(b,e)(1,4) oxazepine are useful for treating or preventing abnormal motor functions of gastrointestinal tracts, e.g., irritable bowel syndrome.
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/27/2003WO2003016306A1 Hiv inhibiting pyrimidines derivatives
02/27/2003WO2003016304A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
02/27/2003WO2003016286A1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
02/27/2003WO2003016284A1 Substituted anthranilamides for controlling invertebrate pests
02/27/2003WO2003016283A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
02/27/2003WO2003016282A2 Substituted 1h-dihydropyrazoles, their preparation and use
02/27/2003WO2003016275A1 Antiviral agent
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof
02/27/2003WO2003015774A1 Compounds effecting glucokinase
02/27/2003WO2003015772A1 Inhibitors of polyq-aggregation
02/27/2003WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/27/2003WO2003015703A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
02/27/2003WO2003015519A1 Arthropodicidal anthranilamides
02/27/2003WO2003015518A1 Method for controlling particular insect pests by applying anthranilamide compounds
02/27/2003WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/27/2003WO2002089782A3 Dioxanes and uses thereof
02/27/2003WO2002080853A3 Fused heterocyclic inhibitors of factor xa
02/27/2003WO2002080841A3 Antibacterial oxazolidinones with a cyclic sulphilimine or sulphoximine
02/27/2003WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
02/27/2003WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
02/27/2003WO2001098267A8 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity
02/27/2003US20030040633 Useful for therapy of HIV-related diseases based on its inhibitory action on proteases derived from viruses
02/27/2003US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
02/27/2003US20030040630 Method for producing sulfonyl imidazole derivatives
02/27/2003US20030040608 Having good hue and capable of forming images having high lightfastness
02/27/2003US20030040534 For therapy of pulmonary hypertension, particularly primary pulmonary hypertension; benign prostatic hypertrophy; migraine; renal, glomerular or mesangial cell disorders; endotoxemia; ischemia; atherosclerosis; restenosis
02/27/2003US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 647